Showing 1–20 of 20 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Nigussie Assefa Kassaw, Jemal Haidar, Dawit Getachew Assefa, Daniel Fiseha, Dereje Habte, et al.
…sis (MDR-TB) and Tuberculosis/Human Immunodeficiency Virus (TB/HIV). Given the public health importance of the problem, it is apparent that probing the work done in this regard is essential to mitigate the problem and thus we reviewed research repositories and compile directories…
Wang DM, Li QF, Zhu M, Xu YH, Liao Y
…extrapulmonary tuberculosis/human immunodeficiency virus (EPTB/HIV) co-infection patients, especially the resistance profile of culture-confirmed EPTB. The purpose of our study was to analyse the clinical characteristics, common sites and drug resistance profile of culture-confir…
N. A. Sosova, T. A. Zadremaylova, Н. М. Коновалова, A. V. Abramchenko, M. I. Romanova, et al.
…stant tuberculosis (MDR, pre-XDR, XDR and HIV infection (DR TB/HIV Group ) and 707 patients with drug resistant tuberculosis (MDR, pre-XDR, and XDR) (and negative HIV status (DR TB Group). The immune status of patients in DR TB/HIV Group and its impact on the effectiveness of tub…
O. V. Filinyuk, A. S. Аlliluev, D. E. Аmichba, П. Н. Голубчиков, Yu. S. Popelo, et al.
…on, the level of primary MDR reaches 31.3% in patients with TB/HIV co-infection, while in HIV negative tuberculosis patients, this rate is 24.2%. The incidence of primary MDR/XDR MTB reaches 40% among deceased patients with TB/HIV co-infection. Treatment efficacy in MDR/XDR TB pa…
Margherita Bracchi, Clare van Halsema, Frank A. Post, Funmi Awosusi, Alison Barbour, et al.
…tlined in Appendix 2. BHIVA guidelines for the treatment of TB/HIV co-infection were last published in 2011 4. For the 2017 guidelines, Medline, EMBASE and the Cochrane Library were searched between August 2015 and January 2016. Abstracts from selected conferences (see Appendix 2…
M.І. Sakhelashvili, Z.I. Pіskur, O.I. Sakhelashvili–Bil, I. V. Yurchenko
…ted to disability in 24.4 % (10) of patients with sensitive TB/HIV and in 55.7 % (34) with chemoresistant TB/HIV or even death in 11.9 % and 26.2 %, respectively.
Jin-Long Li, Chun-Lei Zhang, Yue Feng, Di Li, Hao Zhang, et al.
… problem globally. China is the high-burden country for TB, TB/HIV and MDR/rifampicin-resistant TB (RR-TB) in the period 2021–2025. Heilongjiang Province, located in the northeast of China and is the border region with the Russian Federation, which is also a high-burden co…
Natália Rocha Almeida, Caio Azevedo Lima, Natália Lopes de Freitas, Fabiana Brandão
…vertheless, children show better outcomes among patients in TB/HIV co-infection studies, even after second-line treatment fails. These results demonstrate the complexity and seriousness of co-infection epidemiology, treatment, follow-up, and margin of success. Aggravated by facto…
Yin Mon Thant
…sition plan of fully oral treatment for DR-TB. Furthermore, TB/HIV collaborative activities are established nationwide. With the impact of the coronavirus disease 2019 (COVID-19) pandemic, it is inevitable to have setbacks in the management of TB, together with other non-COVID di…
T.I. Danilova, Yu.V. Korneev, D.А. Kudlаy, N. Yu. Nikolenko
… and extensive drug resistance (MDR/XDR MTB). Patients with TB/HIV co-infection providethe significant impact on the situation. The objective of the study is to assess outcomes of chemotherapy regimens containing bedaquiline in patients with MDR/XDR TB including those with concur…
N.А. Lytvynenko, Yu. I. Feshchenko, Maryna Pohrebna, Yu.О. Senko, Л.М. Процик, et al.
…nts in the outpatient phase of treatment. Immunodeficiency (TB/HIV co-infection) is not the main factor in reducing efficiency: the proportion of HIV deaths has remained unchanged over the past 10 years.Conclusions. All the studied trends are a modern pathomorphosis of tuberculos…
Kabelo Gabriel Kaapu, Ivy Rukasha
…ly among XDR-TB and HIV co-infected patients. Strengthening TB/HIV integration, expanding access to new drug regimens, and enhancing early diagnosis are essential to improve outcomes in rural high-burden settings.
Kabahita JM, Kabugo J, Kakooza F, Adam I, Guido O, et al.
…nda remains one of the countries with the highest burden of TB/HIV. Drug-resistant TB remains a substantial challenge to TB control globally and requires new strategic effective control approaches. Drug resistance usually develops due to inadequate management of TB patients inclu…
Mojisola Clara Hosu, Urgent Tsuro, Ntandazo Dlatu, Lindiwe Modest Faye, Teke Apalata
…ted that improved clinical governance via better follow-up, TB/HIV integration, and adherence support could improve treatment success by up to 20 percentage points in high-impact scenarios.: Strengthening clinical governance through targeted interventions could substantially redu…
Mohammadzadeh R, Ghazvini K, Farsiani H, Soleimanpour S
…ensively drug-resistant tuberculosis (MDR- and XDR-TB), and TB/HIV co-infection make TB a global health problem, which emphasises the design and development of efficient vaccines and diagnostic biomarkers. Extracellular vesicles (EVs) secretion is a conserved phenomenon in all th…
Mhango DV, Mzinza DT, Jambo KC, Mwandumba HC
…n resource-limited regions has simplified the management of TB/HIV coinfected patients and minimized serious adverse events. Summary While it is unequivocal that substantial progress has been made in early detection and treatment of HIV-associated TB, significant therapeutic chal…
Yesypenko S, Grigoryan R, Sereda Y, Denisuk O, Kovtunovich L, et al.
Introduction Odesa province has the highest TB/HIV prevalence in Ukraine, exceeding the total prevalence in the country by 3 times. The objective of this study was to investigate the unfavorable treatment outcomes and associated factors in patient with drug-resistant (DR) TB in p…
Riccardi N, Pontarelli A, Alagna R, Saderi L, Ferrarese M, et al.
…ale. Median (interquartile range) age was 32 (26-39) years. TB/HIV coinfection was found in 12 (10.3%) patients. Pulmonary TB was diagnosed in 107/116 (92.2%) patients. Resistance to fluoroquinolones and second-line injectables was detected in 22/116 (19.0%) and 12/107 (11.2%) pa…
Abenezer Abraham Anito, Gemechis Abdissa, Yohannis Gezahegn, Ebrahim Umer Muhammed, Hunde Lemi
…sitivity analysis. Targeted adherence support, strengthened TB/HIV integration, and improved programmatic monitoring are essential to further reduce mortality and loss to follow-up.
Érica Chimara, Pedro Eduardo Almeida da Silva, Kleydson Bonfim Andrade Alves, Andréa Villarino, Gabriela Gago, et al.
… health service organization factors.Thus, problems such as TB/HIV coinfection, the increase in diabetes, smoking and other chronic diseases are added to factors such as malnutrition, the use of psychoactive substances and limited access to health services.These factors are accen…